ConductScience.org, home

Paper · 39202808

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135771623Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels.Br J Pharmacol2022https://conductscience.org/library/papers/35771623PubMed
233501656A plant-derived TRPV3 inhibitor suppresses pain and itch.Br J Pharmacol2021https://conductscience.org/library/papers/33501656PubMed
328377424The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases.Mol Pharmacol2017https://conductscience.org/library/papers/28377424PubMed
433876725Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine.Elife2021https://conductscience.org/library/papers/33876725PubMed
522405088Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.Am J Hum Genet2012https://conductscience.org/library/papers/22405088PubMed
634472684Structural mechanism of TRPV3 channel inhibition by the plant-derived coumarin osthole.EMBO Rep2021https://conductscience.org/library/papers/34472684PubMed
735256942Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus.Acta Pharm Sin B2022https://conductscience.org/library/papers/35256942PubMed
836677834TRPV3: Structure, Diseases and Modulators.Molecules2023https://conductscience.org/library/papers/36677834PubMed
935038353Transient receptor potential vanilloid 3 expression is increased in non-lesional skin of atopic dermatitis patients.Exp Dermatol2022https://conductscience.org/library/papers/35038353PubMed
1034245864Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer.Pharmacol Res2021https://conductscience.org/library/papers/34245864PubMed
1138043155Inhibition of Ca2+-permeable TRPV3 and inflammatory cytokine release by honokiol and magnolol in human epidermal keratinocytes.Biochem Biophys Res Commun2024https://conductscience.org/library/papers/38043155PubMed
1229802912Caffeic acid prevents UVB radiation induced photocarcinogenesis through regulation of PTEN signaling in human dermal fibroblasts and mouse skin.Toxicol Appl Pharmacol2018https://conductscience.org/library/papers/29802912PubMed
1336302896Structural basis of TRPV3 inhibition by an antagonist.Nat Chem Biol2023https://conductscience.org/library/papers/36302896PubMed
1431234539Caffeic Acid Phenethyl Ester Inhibits UV-Induced MMP-1 Expression by Targeting Histone Acetyltransferases in Human Skin.Int J Mol Sci2019https://conductscience.org/library/papers/31234539PubMed
1533035568Novel insights into the TRPV3-mediated itch in atopic dermatitis.J Allergy Clin Immunol2021https://conductscience.org/library/papers/33035568PubMed
1631983608Anti-pruritic and anti-inflammatory effects of natural verbascoside through selective inhibition of temperature-sensitive Ca2+-permeable TRPV3 channel.J Dermatol Sci2020https://conductscience.org/library/papers/31983608PubMed
1726098639Antioxidant Activity of Caffeic Acid against Iron-Induced Free Radical Generation--A Chemical Approach.PLoS One2015https://conductscience.org/library/papers/26098639PubMed
1830377214
Pharmacological Inhibition of the Temperature-Sensitive and Ca2+-Permeable Transient Receptor Potential Vanilloid TRPV3 Channel by Natural Forsythoside B Attenuates Pruritus and Cytotoxicity of Keratinocytes.
J Pharmacol Exp Ther2019https://conductscience.org/library/papers/30377214PubMed
1931152005Pharmacological Activation of Thermo-Transient Receptor Potential Vanilloid 3 Channels Inhibits Hair Growth by Inducing Cell Death of Hair Follicle Outer Root Sheath.J Pharmacol Exp Ther2019https://conductscience.org/library/papers/31152005PubMed
2036979447Novel Insights into the Role of Keratinocytes-Expressed TRPV3 in the Skin.Biomolecules2023https://conductscience.org/library/papers/36979447PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/39202808/references